Stocks
Intellia Therapeutics (NTLA) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 2.59 | 4.28 | 3.88 | 2.51 | 1.57 | 1.05 | |||
| Changes by years, y/y, % | -25% | +65% | -9% | -35% | -37% | -14.6% | |||
Intellia Therapeutics. Debt/EBITDA
Intellia Therapeutics. Debt/EBITDA, changes, %
Intellia Therapeutics (NTLA) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | 1.83 | 1.56 | 1.33 | 1.14 | 1.05 | 1.05 | ||
| Changes by years, y/y, % | +4% | -39% | -47% | -47% | -42% | |||
| Changes by quarters, q/q, % | -14% | -15% | -15% | -15% | -7% | |||
